Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Shukra Pharmaceuticals Ltd Stock Analysis

Small Cap
Evaluated by 36 users | BSE: 524632 | NSE: |
Pharmaceuticals & Drugs

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Capital Employed 10.26%14.86%-6.57%-9.09%-6.25%-1.05%3.43%3.52%3.35%2.31%-0.15%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 8.69.96.65.14.42.64.85.15.35.711.914
Y-o-Y Gr. Rt.-14.3%-32.8%-22.9%-13.3%-41.8%87.2%6.4%3.9%6%109.4%-
Adjusted EPS (Rs.) 0.240.59-0.5-0.85-4.82-0.993.23.23.372.95-0.230.21
Y-o-Y Gr. Rt.-145.8%-184.8%NANANANA0%5.3%-12.5%-107.8%-
Book Value per Share (Rs.) -0.180.581.64-0.4288.2989.1389.8993.195.8698.298.4399.84
Adjusted Net Profit 0.30.7-0.6-1-0.8-0.20.50.50.50.500
Net Op. Cash Flow (Rs. Cr.) 0.11.6-7.110.4-3.1-22.7-0.30.80.31.2-
Debt to Cash Flow from Ops 109.83.19-1.470.97-0.1-0.590.01-0.124.2823.386.49-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Shukra Pharmaceuticals Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales 2.1%35.7%32.1%109.4%
Adjusted EPS -190.1%NA-141.6%-107.8%
Book Value per Share 76.921.90.2
Share Price - 1.5% 27.7% 142.1%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20TTM
Return on Equity (%) -94.33392.22-59.68-193.34-11.26-1.123.573.53.573.04-0.230.21
Operating Profit Margin (%) 11.2111.264.3310.09-2.11-9.5824.5428.5130.2329.1413-6.17
Net Profit Margin (%) 3.337.12-8.96-19.71-17.01-6.0310.389.759.888.16-0.30.23
Debt to Equity -36.1910.077.12-23.490.020.09000.240.390.520.67
Working Capital Days 289277612601390879392379467526334473
Cash Conversion Cycle 10974161179901657564314039287
Loading price chart...
Entity Percentage Holding
Promoters 49.17%
Institutions 0.80%
Non-Institutions 50.04%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Shukra Pharmaceuticals Ltd's earnings have grown by 0%, whereas share price has appreciated 1.5% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Data is not available for this company

Data is not available for this company.

Shukra Pharmaceuticals is an ambitious organisation with a deep rooted focus on sustainability with its impressive range of solutions. The company is committed to deliver excellence across National & Global markets. It is a public limited organisation with globally acclaimed manufacturing facilities.

The company is strongly committed to its values that guide it - The Shukra Group in serving the needs of its

Shukra Pharmaceuticals is an ambitious organisation with a deep rooted focus on sustainability with its impressive range of solutions. The company is committed to deliver excellence across National & Global markets. It is a public limited organisation with globally acclaimed manufacturing facilities.

The company is strongly committed to its values that guide it - The Shukra Group in serving the needs of its stakeholders including customers, suppliers, employees and other interest groups by large. Shukra stands for uncompromising quality and efficiency to deliver proven solutions delivered by passionate and motivated team of individuals.

The company boasts fully integrated structure for manufacturing general formulations like Tablet, Capsules and small volume parenteral since 2017. Along with internationally accredited facilities it invests in people.

The company has embarked upon its ambitious journey in the field of Pharamaceutical (date of inception) with a fully integrated plant in Rakanpor in Kalol, Gandhinagar - Gujarat. Since then, there was no looking back, within a short span of (years) the company has come a long way in making its mark in the sector.

The company has now developed an internationally accredited Laboratory in Ahmedabad where each product and solutions are developed under stringent quality processes.

Business area of the company

The company is engaged in the business of manufacturing and trading of pharmaceuticals Products, laboratory testing.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback